2-(2-Ethoxyethoxy)-5-bromopyridine

Catalog No.: 
ACRLCT879
CAS No.: 
1249442-19-0
Molecular Formula: 
C9H12BrNO2
Molecular Weight: 
246.10
2-(2-Ethoxyethoxy)-5-bromopyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$393.00InquiryInquiry
250mg95%$641.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Ethoxyethoxy)-5-bromopyridine
IUPAC Name5-bromo-2-(2-ethoxyethoxy)pyridine
MDL No.MFCD14652079
Molecular FormulaC9H12BrNO2
Molecular Weight246.10
SMILESBrC1=CN=C(OCCOCC)C=C1
InChI KeyZBVGEMXJEOQTAF-UHFFFAOYSA-N
Synonym2-(2-ethoxyethoxy)-5-broMopyridine;5-bromo-2-(2-ethoxyethoxy)Pyridine;Pyridine, 5-bromo-2-(2-ethoxyethoxy)-
CAS No.1249442-19-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACRLCT879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRLCT879 route product structure diagram
    ACRLCT8791249442-19-0
Inquiry

2. ACRLCT879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYIHU365 route compound structure diagram
    ACYIHU36553939-30-3In Stock
  4. Then
  5. ACRLCT879 route product structure diagram
    ACRLCT8791249442-19-0
Inquiry

3. ACRLCT879 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIWBF532 route compound structure diagram
    ACIWBF532766-11-0In Stock
  4. Then
  5. ACRLCT879 route product structure diagram
    ACRLCT8791249442-19-0
Inquiry

Comments (0)